Research
New data supports Hoya's DIMS lenses for myopic prevention among preschool-aged pediatrics
Presented at ARVO, updated findings among the younger pre-myopics confirmed a protective effect of the patented and embedded technology on refractive status.
Research
Hoya reports 8-year data on DIMS spectacle lenses for pediatric myopia
Long-term study evaluated myopia control effect and user experience of patients wearing HOYA’s MiYOSMART spectacle lenses.
Research
DIMS spectacle lenses may mitigate pediatric myopia
Second-ever 6-year clinical trial of myopia control shows no rebound effects after cessation of treatment lens wear.Research
Breakthrough trial finds MiYOSMART iQ spectacle lenses halt childhood myopia progression
Latest 12-month data details highest myopia-control efficacy results reported to date in myopes as young as age 4 wearing HOYA’s D.I.M.S. technology.
Research
HOYA reports 6-month data on MiYOSMART iQ spectacle lenses for pediatric myopia
Interim results find advanced lens and D.I.M.S. triple enhanced design tech to be twice as effective in controlling axial elongation and disease progression.
Products
Hoya Vision launches spectacle lenses for pediatric myopia protection
The MiYOSMART photochromic and polarized spectacle lenses incorporate D.I.M.S. technology.
Business
NeuroVision expands retinal imaging-based neurodegenerative disease detection with new acquisition
Retinal imaging developer adds Durin Life Sciences’ noninvasive, blood-based biomarker test to its integrated platform targeting cognitive diseases.
Research
Real-world TED data finds disease advances beyond acute phase
Real-world study demonstrates heterogeneous disease progression in TED, challenging the traditional self-limited paradigm.
Products
Marco Lombart named exclusive US distributor for Haag-Streit diagnostic technology
Agreement extends to the Lenstar 900 optical biometer and Octopus 600 and 900 perimeter devices.
Research
Could human breast milk treat dry eye disease?
Narrative review traces ophthalmic uses of human milk back to anciant Egyptian papyrus, finding the biology behind it might hold up.
Research
Dry eye may indicate early signs of autoimmune disease
Study findings suggest ocular surface symptoms may precede systemic autoimmune diagnosis by several years.
Research
Study: CV risk score identifies future eye disease risk
Pooled Cohort Equations (PCE) score may help identify high-risk patients when preventive measures may protect their vision.
Research
Study correlates visual impairment with sleep disruptions
Poor sleep quality associated with a significantly higher risk of visual impairment, diabetic retinopathy, and other ocular conditions.
Legal
Samsung Bioepis and Regeneron settle EYLEA biosimilar US patent dispute
Settlement and license agreement clears the way for a January 2027 commercial launch of OPUVIZ 2 mg (aflibercept-yszy) injection.
Research
Cannabis implicated in ocular inflammatory disease development
Cannabis use associated with higher risk of developing uveitis and other posterior segment diseases.
Pipeline
Novartis's ianalumab earns FDA Breakthrough Therapy designation for Sjögren’s disease
Fully human monoclonal antibody is delivered as a monthly subcutaneous injection; company plans to submit for global approval in early 2026.
Business
Topcon and RemoniHealth to advance AI-based chronic eye disease monitoring
New partnership will integrate remote at-home vision testing with Topcon’s connected care model to support ongoing Healthcare from the Eye initiative.
Research
Beta-zone PPA may be major glaucoma disease marker for Black patients
Beta-zone PPA was linked with RNFL thinning, suggesting it may be a feature of glaucomatous change.
Products
Euclid Vision launches new SiHy daily disposable lens for myopia
The Be Free Day soft lens for pediatric myopes features BHVI's proprietary dual action, multistep optical design technology.
Products